Biological and imaging biomarkers for predicting prognosis of chronic kidney disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046519

Enrollment

Unknown

Registered

2021-05-19

Start date

2017-01-17

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-80 years; 2.Renal biopsy was completed in our hospital, or genetic examination was completed; 3.Patients who met the diagnostic criteria for CKD, either kidney damage or GFR of less than 60ml/min/1.73m2 of body surface area lasting for longer than 3 months. Kidney damage can be pathological morphological abnormalities of the kidney, or abormalities in blood, urine test or renal imaging; 4.Voluntary participation, and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with other comorbidities that could affect the volume or the components of the kidney, such as renal cysts, polycystic kidney disease, medullary sponge kidney, hydronephrosis, renal artery stenosis, renal vein thrombosis and/or renal tumors; 2.Contraindications for MRI examination; 3.Pregnant or lactation patients; 4.Patients with unstable vital signs, failure of other organs or dysphoria.

Design outcomes

Primary

Measure	Time frame
End stage renal disease;	—

Secondary

Measure	Time frame
All-cause death;Adverse cardiovascular events;More than 30% loss of GFR;	—

Countries

China

Contacts

Public ContactChen Limeng

Peking Union Medical College Hospital

chenlimeng@pumch.cn+86 15801391704

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026